Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a lebanese population: Frequency distribution and association with morbid diseases

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 3, 2010, Pages 393-397

  Zgheib, Nathalie Khoueiry ^a   Mitri, Zahi ^a   Geryess, Eddy ^a   Noutsi, Pakiza ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2E1; CTGCAG-SPECIFIC TYPE II DEOXYRIBONUCLEASES; GTAC-SPECIFIC TYPE II DEOXYRIBONUCLEASES; TTTAAA -SPECIFIC TYPE II DEOXYRIBONUCLEASES; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

AGED; ALLELE; ARTICLE; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HYPERTENSION; LEBANON; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; CYTOCHROME P-450 CYP2E1; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEBANON; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 77954940821     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0193     Document Type: Article

References (49)

1. Abdel-Razzak Z, Corcos L, Fautrel A, et al. (1994) Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol Pharmacol 46:1100-1110.
2. Abdel-Razzak Z, Loyer P, Fautrel A, et al. (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715.
3. Agudo A, Sala N, Pera G, et al. (2006) No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 15:1043-1045.
4. Bartsch H, Nair U, Risch A, et al. (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3-28.
5. Boccia S, Cadoni G, Sayed-Tabatabaei FA, et al. (2008) CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134:93-100.
6. Bolt HM, Roos PH, Thier R (2003) The cytochrome P-450 iso-enzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76:174-185.
7. Boobis AR, Davies DS (1984) Human cytochromes P-450. Xe-nobiotica 14:151-185.
8. Bouchardy C, Hirvonen A, Coutelle C, et al. (2000) Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 87:734-740.
9. Brockmoller J, Cascorbi I, Kerb R, et al. (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56:3915-3925.
10. Caro AA, Cederbaum AI (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44:27-42.
11. Cheng PY, Morgan ET (2001) Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab 2:165-183.
12. Court MH (2008) Hardy-Weinberg equilibrium calculator. Available at Error! Hyperlink reference not valid.20lab%20-%20HW%20calculator.xls. Accessed August 2009.
13. Danko IM, Chaschin NA (2005) Association of CYP2E1 gene polymorphism with predisposition to cancer development. Exp Oncol 27:248-256.
14. Eom SY, Zhang YW, Kim SH, et al. (2009) Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer Causes Control 20:137-145.
15. El-Sibai M, Platt DE, Haber M, et al. (2009) Geographical structure of the Y-chromosomal genetic landscape of the Levant: a coastal-inland contrast. Ann Hum Genet 73:568-581.
16. Grundy SM, Cleeman JI, Merz CN, et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227-239.
17. Hamdy SI, Hiratsuka M, Narahara K, et al. (2002) Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehy-drogenase (DPYD) in the Egyptian population. Br J Clin Pharmacol 53:596-603.
18. Hamdy SI, Hiratsuka M, Narahara K, et al. (2003a) Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol 55:560-569.
19. Hamdy SI, Hiratsuka M, Narahara K, et al. (2003b) Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population. Br J Clin Pharmacol 55:321-324.
20. Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110:559-565.
21. Ingelman-Sundberg M, Daly AK, Nebert DW (2008) Human cytochrome P450 (CYP) allele nomenclature. Available at www.imm.ki.se/CYPalleles. Accessed August 2009.
22. Ingelman-Sundberg M, Johansson I, Yin H, et al.(1993) Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 10:447-452.
23. Kim RB, O'Shea D (1995) Interindividual variability of chlor-zoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 57:645-655.
24. Kocabas NA, Sardas S, Cholerton S, et al. (2002) Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol 76:643-649.
25. Lucas D, Menez C, Girre C, et al. (1995) Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 5:298-304.
26. Marusin AV, Stepanov VA, Spirinova MG, et al. (2007) [Association analysis of gene polymorphism in alcohol metabolizing enzymes with risk for coronory atherosclerosis]. Genetika 43:409-416.
27. Meisel C, Gerloff T, Kirchheiner J, et al. (2003) Implications of pharmacogenetics for individualizing drug treatment and for study design. J Mol Med 81:154-167.
28. Nebert DW, Gonzalez FJ (1987) P450 genes: structure, evolution, and regulation. Annu Rev Biochem 56:945-993.
29. Nelson DR, Kamataki T, Waxman DJ, et al. (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1-51.
30. Nishimoto IN, Hanaoka T, Sugimura H, et al. (2000) Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Epidemiol Biomarkers Prev 9:675-680.
31. O'Shea D, Davis SN, Kim RB, et al. (1994) Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther 56:359-367.
32. Peyvandi F, Spreafico M, Karimi M, et al. (2002) Allele frequency of CYP2C9 gene polymorphisms in Iran. Thromb Haemost 88:874-875.
33. Raucy JL, Kraner JC, Lasker JM (1993) Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol 23:1-20.
34. Reisfeld B, Yang RSH (2004) A reaction network model for CYP2E1-mediated metabolism of toxicant mixtures. Environ Toxicol Pharmacol 18:173-179.
35. Salama SA, Au WW, Hunter GC (2002) Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers. Environ Mol Mutagen 40:153-160.
36. Sepehr A, Kamangar F, Abnet CC, et al. (2004) Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Cancer Lett 213: 195-202.
37. Tanaka E (1999) Update: genetic polymorphism of drug metabolizing enzymes in humans. J Clin Pharm Ther 24:323-329.
38. Tanaka E, Terada M, Misawa S (2000) Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther 25:165-175.
39. Ulusoy G, Adali O, Tumer TB, et al. (2007a) Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia. Oncology 72:125-131.
40. Ulusoy G, Arinc E, Adali O (2007b) Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol 81:711-718.
41. United Nations Development Program (2008) About Lebanon. Available at www.undp.org.lb/about/AboutLebanon.cfm. Accessed on January 26, 2010.
42. Verlaan M, te Morsche RH, Roelofs HM, et al. (2004) Genetic polymorphisms in alcohol-metabolizing enzymes and chronic pancreatitis. Alcohol Alcohol 39:20-24.
43. Watanabe J, Hayashi S, Kawajiri K (1994) Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flanking region. J Biochem 116: 321-326.
44. Wu SH, Tsai SM, Hou MF, et al. (2006) Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits. Breast Cancer Res Treat 100:93-98.
45. Wu X, Amos CI, Kemp BL, et al. (1998) Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev 7:13-18.
46. Wu X, Shi H, Jiang H, et al. (1997). Associations between cyto-chrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18:967-973.
47. Yamada Y, Sun F, Tsuritani I, et al. (2002) Genetic differences in ethanol metabolizing enzymes and blood pressure in Japanese alcohol consumers. J Hum Hypertens 16:479-486.
48. Yang B, O'Reilly DA, Demaine AG, Kingsnorth AN (2001) Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis. Alcohol 23:91-97.
49. Zalloua PA, Xue Y, Khalife J, et al. (2008) Y-chromosomal diversity in Lebanon is structured by recent historical events. Am J Hum Genet 82:873-882.